Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing.

BACKGROUND Lipid abnormalities are major risk factors for premature coronary artery diseases. We investigated serum lipids and the prevalence of dyslipidemia in a professional population in Beijing and compared these data with those obtained in a similar population during 1984-1986. METHODS We studied 14 963 individuals 20-90 years of age. Health status was determined by questionnaires and physical check-ups. Total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), and total triglycerides (TGs) were measured. TC >5.7 mmol/L, LDL-C >3.6 mmol/L, TGs >1.7 mmol/L, and HDL-C <0.9 mmol/L were defined as abnormal. RESULTS Mean serum TC, LDL-C, and TG concentrations were increased compared with the values obtained in 1984-1986, with 52.7% of males and 42.9% of females having at least one abnormal lipid concentration. Hypercholesterolemia occurred in 6% of males and 2.8% of females in the younger group (20-39 years) and in 20.2% of males and 38.7% of females in the older group (>60 years). HDL-C was abnormally low in approximately 7% of males and in 1.6% of females. The prevalences of hypercholesterolemia, hypertriglyceridemia, and abnormally low HDL-C, especially the presence of slight hypertriglyceridemia, were higher than in 1984-1986 in all age groups. The increase was most prominent in the middle age group (40-59 years). CONCLUSIONS Hypercholesterolemia, hypertriglyceridemia, and abnormally low HDL-C have increased considerably over the past 20 years in professional populations in Beijing. Dietary changes and less physical activity resulting from rapid improvements in living conditions may be the causes for the increases. Enhanced preventive measures should be undertaken to modify these situations.

[1]  W. Shu Changes in Serum Total Cholesterol Levels of Beijing Professional Population During 1981~2001 , 2003 .

[2]  Z. Feng-ying THE CHANGING TREND OF DIETARY PATTERN OF CHINESE POPULATION——AN EIGHT PROVINCES CASE STUDY IN CHINA , 2002 .

[3]  F. Martín-Gil,et al.  Comparison of two homogeneous assays with a precipitation method and an ultracentrifugation method for the measurement of HDL-cholesterol. , 1998, Clinical chemistry.

[4]  S. Devaraj,et al.  Evaluation of a rapid homogeneous method for direct measurement of high-density lipoprotein cholesterol. , 1998, American journal of clinical pathology.

[5]  Yang Changguo The evaluation of direct methods for measuring high density lipoprotein cholesterol , 1998 .

[6]  N. Rifai,et al.  Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. , 1997, Clinical chemistry.

[7]  Geke-You The Change of Dietary Pattern of Chinese Populations , 1997 .

[8]  P. Poole‐Wilson,et al.  [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. , 1995, Annales de cardiologie et d'angeiologie.

[9]  Bruce Kinosian,et al.  Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios , 1994, Annals of Internal Medicine.

[10]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[11]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.

[12]  Gail Henderson China: Long-Term Issues and Options in the Health Transition . By The World Bank. [Washington, D.C.: The World Bank, 1992. 133 pp. $10.95. ISSN 0253–2123, ISBN 0–8213–2183–8.] , 1994, The China Quarterly.

[13]  Anahí Gallardo Velázquez,et al.  Conference , 1969, Journal of Neuroscience Methods.

[14]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[15]  NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. , 1993, JAMA.

[16]  W. A. Bradley,et al.  Triglyceride, high density lipoprotein, and coronary heart disease. , 1993, Consensus statement. National Institutes of Health Consensus Development Conference.

[17]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[18]  D. Salem,et al.  Prevalence of risk factors in men with premature coronary artery disease. , 1991, The American journal of cardiology.

[19]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[20]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[21]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[22]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[23]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[24]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[25]  C. E. Becker The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.

[26]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.

[27]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[28]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[29]  W. PCastelli,et al.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. , 1977 .

[30]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[31]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.